Yasser F. Hassan

ORCID: 0000-0001-6335-4891 · 1 paper in corpus

article 2022

Ultra-sensitive and selective fluorescence approach for estimation of elagolix in real human plasma and content uniformity using boron-doped carbon quantum dots

BMC chemistry ·doi:10.1186/s13065-022-00849-3

Elagolix (ELX) is an orally administered non-peptidic GnRH antagonist that has been approved by the Food and Drug Administration in 2018 for the treatment of endometriosis pain. A sensitive and selective method for estimating elagolix (ELX)…